Drug Profile
Influenza virus vaccine trivalent - Novavax
Alternative Names: CadiFlu-S; Influenza virus-like particle vaccine trivalent - Novavax; Novavax trivalent vaccine; Seasonal influenza VLP vaccine - Novavax; VLP-based trivalent seasonal influenza vaccine - NovavaxLatest Information Update: 23 Nov 2016
Price :
$50
*
At a glance
- Originator Novavax
- Developer CPL Biologicals; Novavax
- Class Influenza virus vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections